Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
058
|
Date of Entry 05/30/2022
|
FR Recognition Number
|
6-481
|
Standard | |
ANSI AAMI CN27:2021 General requirements for Luer activated valves (LAVs) incorporated into medical devices for intravascular applications |
|
Scope/AbstractThis standard covers Luer activated valves (LAVs) for intravascular applications, which open and permit access to the fluid conduit when a male Luer connector is inserted.
This standard applies only to the valve end of LAVs.
This standard applies to LAVs as stand-alone devices or as components of a medical device.
This standard does not address valves that are opened by a female Luer connector.
This standard does not address the connection features of the non-valve end of LAVs and/or other integrated features (e.g., stopcock handles) (Figure 1).
|
|
Extent of Recognition
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§880.5440 |
Stopcock, I.V. Set
|
Class 2
|
FMG
|
§880.5440 |
Set, Administration, Intravascular
|
Class 2
|
FPA
|
§880.5440 |
Set, I.V. Fluid Transfer
|
Class 2
|
LHI
|
|
Relevant FDA Guidance and/or Supportive Publications*
Guidance for Industry and FDA Staff - Intravascular Administration Sets Premarket Notification Submissions [510(k)], issued July 11, 2008.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contacts
|
Standards Development Organizations
|
FDA Specialty Task Group (STG)
General Plastic Surgery/General Hospital |
|
*These are provided as examples and others may be applicable. |